REQUEST A DEMO
Total
USD $0.00
Search more companies

Malu Pharm Sp. z o.o. (Poland)

Main Activities: All Other Miscellaneous Food Manufacturing
Full name: Malu Pharm Sp. z o.o. Profile Updated: January 06, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Malu Pharm Sp. z o.o. is based in Poland, with the head office in Lublin. The company operates in the All Other Miscellaneous Food Manufacturing industry. It was established on February 16, 2021. In 2023, the company reported a net sales revenue increase of 988.29%. A negative growth of 3.28% was recorded in its total assets. The net profit margin of Malu Pharm Sp. z o.o. decreased by 68.3% in 2023.

Headquarters
Ul. Jasna 6/19
Lublin; Lubelskie; Postal Code: 20-077

Contact Details: Purchase the Malu Pharm Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Malu Pharm Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Malu Pharm Sp. z o.o. report to view the information.
Incorporation Date:
February 16, 2021
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
95%
Company Performance
Financial values in the chart are available after Malu Pharm Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
988.29%
Total operating revenue
1954.6%
Operating profit (EBIT)
-92.34%
Net Profit (Loss) for the Period
-92.68%
Total assets
-3.28%
Total equity
6.21%
Operating Profit Margin (ROS)
-75.04%
Net Profit Margin
-68.3%
Return on Equity (ROE)
-78.99%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?